Cullinan Therapeutics (CGEM) Proxy filing summary

Voting matters and shareholder proposals

• Election of two Class III directors, Nadim Ahmed and Stephen Webster, for a three-year term ending in 2029.

• Ratification of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.

• Advisory vote to approve named executive officer compensation.

• Board will consider any other business that may properly come before the meeting or any adjournment.

Board of directors and corporate governance

• Board recommends voting in favor of all director nominees and proposals.

Audit committee and external auditor matters

• Proposal to ratify KPMG LLP as the independent auditor for the upcoming fiscal year.